The strategic sale of HD Clinical Limited to NEXUS AG by Oaklins Evelyn Partners marks a significant milestone.
- HD Clinical, founded in 2005, is renowned for its innovative electronic clinical record systems tailored for clinical departments.
- The firm’s expertise in endoscopy and cardiology attracted the listed German organisation, NEXUS AG, to acquire it.
- This cross-border transaction showcases Oaklins Evelyn Partners’ ability to leverage their international network.
- Key individuals involved in the deal shared their satisfaction with the successful outcome.
The strategic acquisition of HD Clinical Limited by NEXUS AG marks a notable event in the healthcare technology sector. Oaklins Evelyn Partners successfully guided this process, ensuring a seamless transition for all parties involved. The focus on clinical departments and management data by HD Clinical Limited highlights their value proposition, which appealed to NEXUS AG’s innovative approach to hospital information systems.
Founded in 2005 by Dr Clive Layton and his team, HD Clinical Limited has been instrumental in advancing electronic clinical record systems. The company’s dedication to addressing the specific needs of clinical departments, particularly in endoscopy and cardiology, set them apart in the competitive landscape.
NEXUS AG, a trailblazer in hospital information systems, has consolidated its position in various diagnostic fields including radiology, pathology, and cardiology. By acquiring HD Clinical, NEXUS aims to further enhance its offerings and solidify its market leadership in these areas.
Oaklins Evelyn Partners executed a highly competitive sale process, which involved negotiating intricate financial and commercial elements. This underscores their proficiency in steering complex deals to fruition, leveraging their extensive international network for optimal results.
Both Dr Clive Layton and Prashant Dhokia highlighted the exceptional support provided by Oaklins Evelyn Partners throughout the transaction. Layton praised the team’s attentiveness and communication, which he noted were pivotal in maintaining the deal’s momentum. This sentiment was echoed by Dhokia, who expressed delight at achieving a favourable outcome for shareholders.
The successful sale of HD Clinical to NEXUS AG underscores the significance of strategic guidance in complex transactions.
